What is the diagnosis and management for a patient with leukocytosis, paresthesia, abnormal arm sensations, back tingling, elevated inflammatory markers, and facial flushing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Adult-Onset Still's Disease (AOSD)

The constellation of leukocytosis, paresthesias, back tingling, elevated inflammatory markers, and facial flushing strongly suggests Adult-Onset Still's Disease (AOSD), particularly when accompanied by the characteristic fever pattern and rash described in this syndrome. 1

Key Diagnostic Features Present

Your patient demonstrates several cardinal manifestations of AOSD:

  • Leukocytosis with neutrophilia: AOSD characteristically produces striking neutrophilia from bone marrow granulocyte hyperplasia, with 50% of patients having peripheral leucocyte counts >15×10⁹ cells/L and 37% exceeding 20×10⁹ cells/L 1

  • Markedly elevated inflammatory markers: ESR is raised in virtually all patients, and CRP is typically very elevated 1

  • Facial flushing with rash: The transient erythematous (salmon pink) rash is a key diagnostic feature that often coincides with fever spikes and preferentially involves the trunk, though facial involvement occurs 1

  • Paresthesias and back tingling: These musculoskeletal symptoms align with the myalgia seen in 56-84% of AOSD patients, which appears generalized and coincides with fever exacerbations 1

Diagnostic Workup Required

Immediately obtain the following laboratory tests to confirm diagnosis and exclude mimics:

  • Serum ferritin level: Expect very high levels (4,000-30,000 ng/ml or even up to 250,000 ng/ml), which correlate with disease activity 1

  • Glycosylated ferritin fraction: If available, levels <20% combined with fivefold serum ferritin elevation provide 43% sensitivity and 93% specificity for AOSD 1

  • Complete blood count with differential: Document the degree of leukocytosis, assess for anemia of chronic disease, and check for thrombocytosis 1

  • Comprehensive metabolic panel: Evaluate for hepatic involvement (present in 50-75% of patients) 1

  • Autoantibody panel (ANA, RF, anti-CCP): These should be negative in AOSD; their presence suggests alternative diagnoses 1

Apply Yamaguchi criteria for diagnosis, which requires:

  • Major criteria: Fever ≥39°C for ≥7 days, arthralgia, typical rash, leukocytosis ≥10,000/μL with ≥80% neutrophils 1
  • Minor criteria: Sore throat, lymphadenopathy/splenomegaly, liver dysfunction, negative RF and ANA 1
  • Diagnosis requires ≥5 criteria including ≥2 major criteria 1

Critical Pitfall: Macrophage Activation Syndrome (MAS)

Monitor vigilantly for MAS, the most life-threatening complication of AOSD, which can occur at onset, during treatment, or even in remission. 1

Watch for these warning signs:

  • Sudden drop in white blood cell count (pancytopenia) 1
  • Persistent high fever despite treatment 1
  • Hepatosplenomegaly with liver dysfunction 1
  • Coagulopathy or disseminated intravascular coagulation 1

If MAS is suspected, immediately check ferritin (often >10,000 ng/ml), triglycerides, fibrinogen, and consider bone marrow examination for hemophagocytosis. This requires urgent immunosuppressive treatment. 1

Management Algorithm

Initial treatment approach:

  1. For moderate disease activity: Start prednisone 0.5-1 mg/kg daily (typically 40-60 mg daily for adults) 1

  2. Monitor response at 1-3 month intervals with ESR, CRP, ferritin, and clinical assessment 1, 2

  3. If inadequate response or steroid-dependent: Add disease-modifying therapy:

    • IL-1 inhibitors (anakinra or canakinumab) are highly effective for AOSD 1, 3
    • IL-6 inhibitors (tocilizumab) as alternative 1
  4. Apply treat-to-target strategy: Adjust DMARDs dynamically based on disease activity, with ultimate goal of drug-free remission 1

  5. NSAIDs alone are insufficient for controlling AOSD and should not be used as monotherapy 1

Differential Diagnoses to Exclude

Before confirming AOSD, rule out:

  • Infections: Obtain blood cultures if fever present; consider endocarditis with echocardiography if murmurs detected 2
  • Malignancy: Particularly lymphoma or leukemia if constitutional symptoms prominent 4, 5
  • Other autoimmune diseases: Giant cell arteritis (if age >50), polymyalgia rheumatica, systemic lupus erythematosus 2
  • Drug-induced conditions: Review medications, particularly immune checkpoint inhibitors if cancer history present 1

The key distinguishing feature is the combination of very high ferritin (often >5× upper limit of normal), negative autoantibodies, and the characteristic fever-rash pattern that defines AOSD. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ESR Values and Clinical Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.